World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02104297
Date of registration: 02/04/2014
Prospective Registration: No
Primary sponsor: Diskapi Yildirim Beyazit Education and Research Hospital
Public title: Effect of Deksmedetomidine and Remifentanil in Extubation Agitation EA
Scientific title: The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation
Date of first enrolment: April 2014
Target sample size: 90
Recruitment status: Not yet recruiting
URL:  http://clinicaltrials.gov/show/NCT02104297
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention  
Phase:  Phase 4
Countries of recruitment
Turkey
Contacts
Name:     Reyhan Polat, MD
Address: 
Telephone:
Email:
Affiliation:  Yildirim Beyazit Education and Research Hospita
Name:     Reyhan Polat, MD
Address: 
Telephone: +905326734310
Email: reyhanp9@gmail.com
Affiliation: 
Name:     Reyhan Polat, MD
Address: 
Telephone: +905326734310
Email: reyhanp9@gmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Adult patients

Exclusion Criteria:

- patients with any sensitivity each drug



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Agitation
Intervention(s)
Drug: Saline
Drug: deksmedetomidine
Drug: Remifentanil
Primary Outcome(s)
To asses postoperative agitation score by Riker sedation agitation scale [Time Frame: Postoperative first hour]
Secondary Outcome(s)
Yo asses postoperative side effects emesis, vomitting or pain [Time Frame: Postoperative first hour]
Secondary ID(s)
Agitation
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history